tiprankstipranks
Trending News
More News >
Houlihan Lokey (HLI)
NYSE:HLI

Houlihan Lokey (HLI) AI Stock Analysis

Compare
194 Followers

Top Page

HLI

Houlihan Lokey

(NYSE:HLI)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
$201.00
â–²(19.42% Upside)
The score is driven primarily by strong financial performance and a constructive earnings call (growth, pipeline visibility, and balance sheet strength). Offsetting factors are a softer technical backdrop and a relatively high P/E, with the dividend providing only modest valuation support.
Positive Factors
Revenue Growth
Consistent revenue and earnings growth indicate strong demand for services and effective business strategies, supporting long-term expansion.
Conservative Leverage
A conservative leverage profile enhances financial stability and flexibility, allowing the company to navigate economic fluctuations effectively.
Non-U.S. Business Expansion
Expanding presence in international markets diversifies revenue streams and reduces dependency on the U.S. market, supporting long-term growth.
Negative Factors
Decreased Average Transaction Fees
Decreased transaction fees could pressure profit margins, impacting revenue per deal and potentially affecting overall profitability.
Slowdown in Restructuring Activity
A slowdown in restructuring activity may reduce revenue from this segment, affecting growth if not offset by other business areas.
Increased Compensation Expenses
Rising compensation expenses can strain profit margins, requiring careful management to maintain profitability while attracting talent.

Houlihan Lokey (HLI) vs. SPDR S&P 500 ETF (SPY)

Houlihan Lokey Business Overview & Revenue Model

Company DescriptionHoulihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.
How the Company Makes MoneyHoulihan Lokey generates revenue primarily through advisory fees associated with its financial advisory services, which include M&A advisory, capital raising, and financial restructuring services. The firm earns a substantial portion of its income from success fees tied to completed transactions, alongside retainer fees for ongoing advisory relationships. Additionally, Houlihan Lokey engages in valuation services, providing independent assessments that contribute to its revenue. The company benefits from its extensive network and reputation in the mid-market sector, leading to repeat business and referrals. Strategic partnerships with financial institutions and private equity firms also enhance its capabilities and market access, further contributing to its earnings.

Houlihan Lokey Earnings Call Summary

Earnings Call Date:Jan 28, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call delivered multiple clear positive operating and strategic signals: double-digit revenue and EPS growth, strong performance across core businesses (notably Corporate Finance and Restructuring this quarter), an expanding European presence via targeted acquisitions, a healthy balance sheet (~$1.2B cash), and top-market industry rankings. Offsetting items are manageable: rising absolute compensation and non-comp costs (though ratios are stable), localized cost pressure from acquisitions, and caution about restructuring revenue as markets improve plus macro/geopolitical uncertainty. Overall, the positives — revenue/earnings growth, deal pipeline strength, strategic M&A and market share momentum — outweigh the cautions.
Q3-2026 Updates
Positive Updates
Strong Quarter — Revenue and EPS Growth
Total revenues of $717 million, up 13% year-over-year; adjusted EPS of $1.94, up 18% year-over-year.
Corporate Finance Momentum
Corporate Finance revenue of $474 million, up 12% year-over-year; closed 177 transactions vs. 170 a year ago; average transaction fee increased and new-business activity trending upward, supporting optimism for fiscal 2027.
Financial Restructuring Outperformed Seasonality
Restructuring revenue of $156 million, up 19% year-over-year; closed 41 transactions (flat YoY) with higher average fees; several deals accelerated into Q3, producing a stronger-than-typical Q3 and reversing the usual seasonal pattern.
Financial & Valuation Advisory Growth
Revenue of $87 million, up 6% year-over-year; 1,103 fee events vs. 1,015 a year ago (10% increase), with solid new business heading into Q4.
Strategic M&A and European Expansion
Completed acquisition of Mellon Capital's real estate advisory business and announced agreement for a controlling interest in O'Dare Partners (France) to increase European footprint (expected to own 51% at close); hired 6 new managing directors in Q3 and added 11 colleagues in Munich and London.
Balance Sheet Strength and Capital Deployment
Ended quarter with ~ $1.2 billion cash and investments; repurchased ~418,000 shares in Q3; management emphasizes flexibility to deploy cash for strategic acquisitions while continuing measured buybacks.
Industry Recognition and Talent Investment
Named the #1 most active M&A investment bank and #1 most active financial restructuring investment bank globally for 2025; continued hiring and investments across geographies and products (6 MDs hired in Q3).
Improved Tax Efficiency
Adjusted effective tax rate of 30.6% in the quarter versus 33.3% a year ago, driven by decreased state taxes and decreased non-deductible expenses.
Negative Updates
Restructuring Outlook Uncertainty for FY2027
Management expects potential revenue pressures in Financial Restructuring as markets improve (structural decline in demand for restructuring when M&A and capital availability improve), creating uncertainty about near-term restructuring revenue levels despite Q3 strength.
Expense Growth — Compensation and Non-Comp
Adjusted compensation expense rose to $441 million from $390 million YoY; adjusted compensation expense ratio held at 61.5% but absolute compensation increased. Adjusted non-compensation expenses are up 11% year-to-date and the company expects Q4 non-comp growth to be consistent with YTD levels.
Localized Cost Pressure from Acquisitions
Elevated rent and related non-comp costs in Europe tied to recent acquisitions noted; Q3 included $2.2 million integration/acquisition costs and other acquisition-related adjustments.
Market & Macro Uncertainties
Geopolitical events and concerns in private credit markets were cited as variables that could both suppress and unpredictably increase restructuring activity; management flagged these as contributors to uneven visibility.
Q4 Seasonality and Timing Risk
Because several restructuring transactions accelerated into Q3, management expects Q4 to more closely resemble Q1–Q2 and not show the typical seasonal strength, introducing timing risk for quarter-to-quarter comparisons.
Company Guidance
The company guided to continued momentum into fiscal 2027 driven by improving M&A activity and stronger visibility into deal activity/backlog, reporting Q3 revenues of $717 million and adjusted EPS of $1.94 (up 13% and 18% YoY, respectively), with Corporate Finance at $474M (up 12%, 177 closed deals vs. 170), Financial Restructuring $156M (up 19%, 41 deals), and Financial & Valuation Advisory $87M (up 6%, 1,103 fee events vs. 1,015, +10%); they noted Q3 restructuring strength may reverse typical seasonality (Q3 > Q4) but expect restructuring revenues to face pressure in FY27 (though geopolitical risks could increase activity). On costs, adjusted compensation was $441M vs. $390M (adjusted comp ratio 61.5%, target maintained), adjusted non-comp ratio 13.1% (YTD non-comp expenses +11%) with $2.2M, $1.3M and $0.6M of specific adjustments; adjusted tax rate 30.6% (vs. 33.3%). Balance sheet/capital deployment metrics: cash & investments ≈ $1.2B, ~418,000 shares repurchased in Q3, preference to prioritize strategic acquisitions (pipeline described as strong) then dividends/repurchases.

Houlihan Lokey Financial Statement Overview

Summary
Strong overall fundamentals supported by solid income statement (revenue growth and healthy margins), strong cash conversion and rising free cash flow, and a conservative balance sheet with low leverage and solid ROE; minor watch-outs include a slight gross margin decline and some debt increase over time.
Income Statement
85
Very Positive
Houlihan Lokey demonstrates strong financial performance with consistent revenue growth, evidenced by a 3.41% increase in the TTM period. The company maintains healthy profitability margins, including a gross profit margin of 37.22% and a net profit margin of 16.62%. The EBIT and EBITDA margins are also robust at 23.62% and 25.62%, respectively, indicating efficient operational management. Despite a slight decline in gross profit margin compared to the previous year, overall profitability remains strong.
Balance Sheet
78
Positive
The balance sheet reflects a stable financial position with a low debt-to-equity ratio of 0.19, suggesting conservative leverage. The return on equity is solid at 19.66%, indicating effective use of equity to generate profits. The equity ratio stands at 59.22%, highlighting a strong equity base relative to total assets. While the company has managed its debt well, the slight increase in debt levels over the years warrants monitoring.
Cash Flow
82
Very Positive
Cash flow analysis shows positive trends with a 5.96% growth in free cash flow in the TTM period. The operating cash flow to net income ratio is 0.84, reflecting good cash generation relative to net income. The free cash flow to net income ratio is high at 0.95, indicating strong cash conversion. The company has demonstrated consistent improvement in cash flow metrics, supporting its financial flexibility.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.57B2.39B1.91B1.81B2.27B1.53B
Gross Profit954.86M919.92M737.05M696.64M861.32M554.26M
EBITDA657.29M597.59M427.63M435.03M661.40M423.38M
Net Income426.54M399.71M280.30M254.22M437.75M312.77M
Balance Sheet
Total Assets3.79B3.82B3.17B2.97B2.89B2.43B
Cash, Cash Equivalents and Short-Term Investments1.08B1.14B728.80M720.69M833.70M846.85M
Total Debt432.90M438.19M415.41M374.87M197.63M175.33M
Total Liabilities1.55B1.64B1.33B1.36B1.44B1.04B
Stockholders Equity2.25B2.17B1.84B1.61B1.44B1.38B
Cash Flow
Free Cash Flow783.56M808.91M261.73M85.54M727.92M565.69M
Operating Cash Flow817.31M848.61M328.46M136.27M736.60M579.84M
Investing Cash Flow-198.38M-265.06M-70.41M-3.00M-273.91M-99.75M
Financing Cash Flow-397.21M-329.07M-250.59M-240.46M-459.06M-26.82M

Houlihan Lokey Technical Analysis

Technical Analysis Sentiment
Negative
Last Price168.32
Price Trends
50DMA
178.84
Negative
100DMA
186.49
Negative
200DMA
183.35
Negative
Market Momentum
MACD
-1.15
Positive
RSI
31.71
Neutral
STOCH
10.51
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLI, the sentiment is Negative. The current price of 168.32 is below the 20-day moving average (MA) of 182.78, below the 50-day MA of 178.84, and below the 200-day MA of 183.35, indicating a bearish trend. The MACD of -1.15 indicates Positive momentum. The RSI at 31.71 is Neutral, neither overbought nor oversold. The STOCH value of 10.51 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HLI.

Houlihan Lokey Risk Analysis

Houlihan Lokey disclosed 27 risk factors in its most recent earnings report. Houlihan Lokey reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Houlihan Lokey Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$5.77B24.0151.98%3.69%51.19%456.59%
76
Outperform
$13.66B28.3931.39%0.95%27.00%63.47%
74
Outperform
$11.76B25.9420.47%1.33%20.99%25.02%
72
Outperform
$12.56B21.2211.72%1.43%7.54%2.73%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$6.13B26.1819.30%1.63%12.77%36.43%
60
Neutral
$12.65B21.616.13%2.52%-5.41%25.28%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLI
Houlihan Lokey
168.32
-9.90
-5.55%
EVR
Evercore Partners
353.27
73.55
26.29%
JEF
Jefferies
61.18
-11.92
-16.30%
PIPR
Piper Sandler
346.35
35.77
11.52%
SF
Stifel Financial
123.30
12.30
11.09%
MC
Moelis
71.67
-2.85
-3.82%

Houlihan Lokey Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance
Houlihan Lokey Amends and Restates Class B Voting Trust
Neutral
Dec 30, 2025

On December 30, 2025, Houlihan Lokey, Inc. entered into an amended and restated voting trust agreement that replaces its prior 2015 voting trust structure governing Class B common stock. The revised agreement updates termination triggers, including ending the trust 10 years after the date on which all Class B shares convert into Class A or once the trust’s holdings fall below 5% of outstanding common stock, and introduces a requirement that any trust-held stake above 30% of the company’s outstanding shares after that conversion be voted proportionally with other shareholders. It also broadens employee flexibility by allowing former employees (no longer employed for at least 12 months) to have their shares released from the trust after the final conversion date and by expanding circumstances under which employees can withdraw shares for certain pledging, hedging, monetization, or similar transactions, subject to the company’s insider trading policy. Because some directors serve as trustees and hold Class B shares subject to the trust, a special committee of disinterested directors was formed to review and negotiate the new agreement, and, after consulting independent advisors and management, the committee unanimously approved the amended and restated voting trust agreement and authorized officers to execute it, clarifying governance and voting mechanics for major shareholders and employees.

The most recent analyst rating on (HLI) stock is a Buy with a $228.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026